Literature DB >> 33437520

Multidisciplinary lifestyle intervention to manage pancreatic cancer-related cachexia: a case report.

Alice Avancini1, Ilaria Trestini2, Daniela Tregnago2, Alessandro Cavallo3, Marco Bragato3, Clelia Bonaiuto2, Massimo Lanza3, Michele Milella2, Sara Pilotto2.   

Abstract

Pancreatic cancer remains an aggressive disease, with a poor prognosis and a high risk of incurring into cachexia. Supportive care, such as exercise, nutritional and psychological support, may be effective in reducing functional loss, psychological distress and improving nutritional status. We report the effect of 12 weeks of multimodal lifestyle intervention in a 55-year-old female, diagnosed with unresectable body/tail pancreatic cancer and metastasis in the liver, bone, lymph node and lung, to counteract cachexia. The multimodal program resulted safe and feasible. Over 12 weeks, considerable improvements were found in body weight, health-related physical fitness, nutritional status, distress scores, anxiety and depression levels. These findings highlight the potential role of integrated supportive interventions to manage metastatic cancer and cancer-induced cachexia.
© 2020 Alice Avancini, Ilaria Trestini, Daniela Tregnago et al.

Entities:  

Keywords:  cachexia; exercise; lifestyle intervention; metastatic disease; nutrition; pancreatic cancer; psychological support

Year:  2020        PMID: 33437520      PMCID: PMC7787172          DOI: 10.2144/fsoa-2020-0165

Source DB:  PubMed          Journal:  Future Sci OA        ISSN: 2056-5623


  34 in total

1.  Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials.

Authors:  Jens Kondrup; Henrik Højgaard Rasmussen; Ole Hamberg; Zeno Stanga
Journal:  Clin Nutr       Date:  2003-06       Impact factor: 7.324

2.  ESPEN guidelines on nutrition in cancer patients.

Authors:  Jann Arends; Patrick Bachmann; Vickie Baracos; Nicole Barthelemy; Hartmut Bertz; Federico Bozzetti; Ken Fearon; Elisabeth Hütterer; Elizabeth Isenring; Stein Kaasa; Zeljko Krznaric; Barry Laird; Maria Larsson; Alessandro Laviano; Stefan Mühlebach; Maurizio Muscaritoli; Line Oldervoll; Paula Ravasco; Tora Solheim; Florian Strasser; Marian de van der Schueren; Jean-Charles Preiser
Journal:  Clin Nutr       Date:  2016-08-06       Impact factor: 7.324

3.  Anxiety, depression and quality of life in people with pancreatic cancer and their carers.

Authors:  Monika Janda; Rachel E Neale; Kerenaftali Klein; Dianne L O'Connell; Helen Gooden; David Goldstein; Neil D Merrett; David K Wyld; Ingrid J Rowlands; Vanessa L Beesley
Journal:  Pancreatology       Date:  2017-01-20       Impact factor: 3.996

4.  Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA).

Authors:  D Blum; G B Stene; T S Solheim; P Fayers; M J Hjermstad; V E Baracos; K Fearon; F Strasser; S Kaasa
Journal:  Ann Oncol       Date:  2014-02-20       Impact factor: 32.976

5.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Authors:  H A Burris; M J Moore; J Andersen; M R Green; M L Rothenberg; M R Modiano; M C Cripps; R K Portenoy; A M Storniolo; P Tarassoff; R Nelson; F A Dorr; C D Stephens; D D Von Hoff
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

Review 6.  Integration of palliative, supportive, and nutritional care to alleviate eating-related distress among advanced cancer patients with cachexia and their family members.

Authors:  Koji Amano; Vickie E Baracos; Jane B Hopkinson
Journal:  Crit Rev Oncol Hematol       Date:  2019-09-17       Impact factor: 6.312

7.  Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy.

Authors:  Ilaria Trestini; Luisa Carbognin; Isabella Sperduti; Clelia Bonaiuto; Alessandra Auriemma; Davide Melisi; Lisa Salvatore; Emilio Bria; Giampaolo Tortora
Journal:  Eur J Clin Nutr       Date:  2018-03-26       Impact factor: 4.016

Review 8.  Pancreatic cancer.

Authors:  Jorg Kleeff; Murray Korc; Minoti Apte; Carlo La Vecchia; Colin D Johnson; Andrew V Biankin; Rachel E Neale; Margaret Tempero; David A Tuveson; Ralph H Hruban; John P Neoptolemos
Journal:  Nat Rev Dis Primers       Date:  2016-04-21       Impact factor: 52.329

9.  A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.

Authors:  M L Rothenberg; M J Moore; M C Cripps; J S Andersen; R K Portenoy; H A Burris; M R Green; P G Tarassoff; T D Brown; E S Casper; A M Storniolo; D D Von Hoff
Journal:  Ann Oncol       Date:  1996-04       Impact factor: 32.976

10.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

View more
  1 in total

Review 1.  The Psychosocial Components of Multimodal Interventions Offered to People with Cancer Cachexia: A Scoping Review.

Authors:  Jane B Hopkinson
Journal:  Asia Pac J Oncol Nurs       Date:  2021-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.